The central $275 figure reflects five current, individually attributed targets issued after the Lumentum announcement in early November 2026: Piper Sandler (Overweight, $400), B. Riley ($275, Buy), Rosenblatt ($300, Buy), BofA ($225, Neutral, cut from $400), and TD Cowen ($175, Hold, cut from $350). Averaging these gives $275, with a very wide low-to-high range of $175 to $400.
Bullish analysts, led by Piper Sandler's David O'Connor, argue optical components and lasers are becoming an unavoidable bottleneck for next-generation AI clusters and view the selloff as an overreaction to deal structure. More cautious voices, such as BofA and TD Cowen, point to a potentially extended share overhang from the all-stock issuance, integration risk, and lower sector multiples. No analyst currently rates MRVL a Sell, but the dispersion signals genuine uncertainty about whether the deal creates or destroys value per share. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
MRVL traded near $141 in early November 2026, down from roughly $287 a month earlier and well below its 52-week high near $330. Reaching $275 therefore implies about a 95% gain—a very large move by any standard. The path would likely require both a stabilization of the sector and tangible evidence that the Lumentum combination is accretive to earnings per share (EPS), rather than merely dilutive. Marvell reported fiscal second-quarter revenue of about $2.74 billion, up roughly 37% year over year, with data center revenue of about $2.17 billion representing the bulk of sales, and guided third-quarter revenue to about $3.15 billion.
Marvell's core AI business remains intact. Management raised its fiscal 2028 revenue outlook to approximately $18 billion, expects custom silicon revenue to more than double, and projects non-GAAP operating margins entering the high-30s-to-40% range. A newly disclosed custom silicon contract with Google, the earlier Celestial AI acquisition, and the deal's promise of more than $1 billion in run-rate cost synergies all support the long-term case. If integration proceeds smoothly and AI capital expenditure keeps growing, the post-deal earnings base could eventually justify a substantially higher valuation.
The principal obstacle is dilution. Because the Lumentum deal is all-stock, Marvell shareholders will own a materially smaller slice of the combined company, and the transaction is not expected to close until the first half of 2028. Regulatory and integration execution risk, customer concentration among a few hyperscalers, and a sector-wide contraction in semiconductor multiples—triggered in part by a weak forecast from a major chip peer—all weigh on sentiment. A deal spread and fixed exchange ratio also mean further declines in either stock change the value each side ultimately receives.
Marvell's collapse leaves it well below its prior high near $330. A recent intraday trough near $132-$133 stands as near-term support, while the pre-deal $159-$160 zone and the psychological $200 level represent potential resistance on any recovery. The stock's elevated beta means it is likely to remain highly volatile in both directions as the market digests deal specifics.
Most sell-side price targets reflect a roughly 12-month research horizon, though the Lumentum close timeline extends into 2028, creating meaningful differences in how analysts treat dilution. Near term, investors should watch Marvell's fiscal third-quarter results scheduled for December 1, 2026, any updates on the Google custom silicon ramp, analyst target revisions as more firms refresh post-deal estimates, and broader AI capex signals from hyperscalers and chip peers.
In my own analysis, Tickeron's AI Daily Buy/Sell Signals provide a useful layer of AI-driven monitoring for volatile stocks like MRVL. The system scans thousands of names in real time and flags shifts in technical behavior and market conditions, which can help surface potential entry or exit points more efficiently than reviewing charts manually. I find it particularly helpful for tracking high-beta semiconductor names amid deal-related noise and sector swings.
The $275 target is a calculated average of five recent post-deal analyst targets, not an official consensus, and it sits far above the current price. Reaching it would require a roughly 95% move driven by successful Lumentum integration, sustained data center growth, and restored sector multiples. The wide $175-to-$400 range shows analysts themselves disagree sharply on the deal's ultimate value. For now, execution, dilution math, and AI spending trends will determine whether MRVL can rebuild toward that level.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +7.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where MRVL advanced for three days, in 249 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
MRVL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MRVL as a result. In 75 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.
The Moving Average Convergence Divergence Histogram (MACD) for MRVL turned negative on October 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 38 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.
MRVL moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MRVL crossed bearishly below the 50-day moving average on October 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 69%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRVL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The Aroon Indicator for MRVL entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 52 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. MRVL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 70 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MRVL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock better than average.
The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.848) is normal, around the industry mean (5.443). P/E Ratio (46.144) is within average values for comparable stocks, (15.640). Projected Growth (PEG Ratio) (1.340) is also within normal values, averaging (3.803). Dividend Yield (0.002) settles around the average of (0.014) among similar stocks. P/S Ratio (21.552) is also within normal values, averaging (46.468).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company which engages in the business of providing semiconductors to high-performance application-specific standard products
Industry Semiconductors